A study in healthy subjects investigating the safety, tolerability and concentrations of FE 999301 after single and multiple doses
000414
Phase 1 other active
Quick answer
A study in healthy subjects investigating the safety, tolerability and concentrations of FE 999301 after single and multiple doses for Inflammatory Gastrointestinal Disease is a Phase 1 program (other) at Ferring Pharmaceuticals A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ferring Pharmaceuticals A/S
- Indication
- Inflammatory Gastrointestinal Disease
- Phase
- Phase 1
- Modality
- other
- Status
- active